<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<HTML xmlns:o = "urn:schemas-microsoft-com:office:office" xmlns:st1 =
"urn:schemas-microsoft-com:office:smarttags"><HEAD><TITLE>NANOTECHNOLOGY IN PHARMACEUTICALS AND BIOTECH, 24-26 April 2006</TITLE>
<META http-equiv=Content-Type content="text/html; charset=iso-8859-1">
<META content=Word.Document name=ProgId>
<META content="MSHTML 6.00.2900.2802" name=GENERATOR>
<META content="Microsoft Word 9" name=Originator><LINK
href="./NANOTECHNOLOGY%20IN%20PHARMACEUTICALS%20AND%20BIOTECH_files/filelist.xml"
rel=File-List><!--[if gte mso 9]><xml>
<o:DocumentProperties>
</xml><![endif]--><!--[if gte mso 9]><xml>
<w:WordDocument>
<w:DisplayHorizontalDrawingGridEvery>0</w:DisplayHorizontalDrawingGridEvery>
<w:DisplayVerticalDrawingGridEvery>0</w:DisplayVerticalDrawingGridEvery>
<w:UseMarginsForDrawingGridOrigin/>
<w:Compatibility>
<w:FootnoteLayoutLikeWW8/>
<w:ShapeLayoutLikeWW8/>
<w:AlignTablesRowByRow/>
<w:ForgetLastTabAlignment/>
<w:LayoutRawTableWidth/>
<w:LayoutTableRowsApart/>
</w:Compatibility>
</w:WordDocument>
</xml><![endif]-->
<STYLE>@font-face {
font-family: Arial Unicode MS;
}
@font-face {
font-family: @Arial Unicode MS;
}
P.MsoNormal {
FONT-SIZE: 10pt; MARGIN: 0in 0in 0pt; FONT-FAMILY: "Times New Roman"; mso-ansi-language: EN-GB; mso-style-parent: ""; mso-pagination: widow-orphan; mso-fareast-font-family: "Times New Roman"
}
LI.MsoNormal {
FONT-SIZE: 10pt; MARGIN: 0in 0in 0pt; FONT-FAMILY: "Times New Roman"; mso-ansi-language: EN-GB; mso-style-parent: ""; mso-pagination: widow-orphan; mso-fareast-font-family: "Times New Roman"
}
DIV.MsoNormal {
FONT-SIZE: 10pt; MARGIN: 0in 0in 0pt; FONT-FAMILY: "Times New Roman"; mso-ansi-language: EN-GB; mso-style-parent: ""; mso-pagination: widow-orphan; mso-fareast-font-family: "Times New Roman"
}
H1 {
FONT-WEIGHT: bold; FONT-SIZE: 10pt; MARGIN: 0in 0in 0pt; FONT-FAMILY: Arial; mso-ansi-language: EN-GB; mso-pagination: widow-orphan; mso-fareast-font-family: "Times New Roman"; mso-bidi-font-weight: normal; mso-bidi-font-family: "Times New Roman"; mso-style-next: Normal; mso-outline-level: 1; mso-font-kerning: 0pt
}
H2 {
FONT-WEIGHT: bold; FONT-SIZE: 10pt; MARGIN: 0in 0in 0pt; COLOR: red; FONT-FAMILY: Arial; TEXT-ALIGN: center; mso-ansi-language: EN-GB; mso-pagination: widow-orphan; mso-fareast-font-family: "Times New Roman"; mso-bidi-font-weight: normal; mso-bidi-font-family: "Times New Roman"; mso-style-next: Normal; mso-outline-level: 2
}
H3 {
FONT-WEIGHT: normal; FONT-SIZE: 12pt; MARGIN: 0in 0in 0pt; FONT-FAMILY: "Times New Roman"; TEXT-DECORATION: underline; mso-ansi-language: EN-GB; mso-pagination: widow-orphan; mso-fareast-font-family: "Times New Roman"; mso-style-next: Normal; mso-outline-level: 3; text-underline: single; mso-bidi-font-size: 10.0pt
}
H5 {
FONT-WEIGHT: normal; FONT-SIZE: 12pt; MARGIN: 0in 0in 0pt; FONT-FAMILY: "Times New Roman"; mso-ansi-language: EN-GB; mso-pagination: widow-orphan; mso-fareast-font-family: "Times New Roman"; mso-style-next: Normal; mso-outline-level: 5; mso-bidi-font-size: 10.0pt
}
P.MsoBodyText {
FONT-SIZE: 12pt; MARGIN: 0in 0in 0pt; FONT-FAMILY: Arial; mso-ansi-language: EN-US; mso-pagination: widow-orphan; mso-fareast-font-family: "Times New Roman"
}
LI.MsoBodyText {
FONT-SIZE: 12pt; MARGIN: 0in 0in 0pt; FONT-FAMILY: Arial; mso-ansi-language: EN-US; mso-pagination: widow-orphan; mso-fareast-font-family: "Times New Roman"
}
DIV.MsoBodyText {
FONT-SIZE: 12pt; MARGIN: 0in 0in 0pt; FONT-FAMILY: Arial; mso-ansi-language: EN-US; mso-pagination: widow-orphan; mso-fareast-font-family: "Times New Roman"
}
P.MsoBodyText2 {
FONT-SIZE: 12pt; MARGIN: 0in 0in 0pt; FONT-STYLE: italic; FONT-FAMILY: "Times New Roman"; mso-ansi-language: EN-GB; mso-pagination: widow-orphan; mso-fareast-font-family: "Times New Roman"; mso-bidi-font-size: 10.0pt; mso-bidi-font-style: normal
}
LI.MsoBodyText2 {
FONT-SIZE: 12pt; MARGIN: 0in 0in 0pt; FONT-STYLE: italic; FONT-FAMILY: "Times New Roman"; mso-ansi-language: EN-GB; mso-pagination: widow-orphan; mso-fareast-font-family: "Times New Roman"; mso-bidi-font-size: 10.0pt; mso-bidi-font-style: normal
}
DIV.MsoBodyText2 {
FONT-SIZE: 12pt; MARGIN: 0in 0in 0pt; FONT-STYLE: italic; FONT-FAMILY: "Times New Roman"; mso-ansi-language: EN-GB; mso-pagination: widow-orphan; mso-fareast-font-family: "Times New Roman"; mso-bidi-font-size: 10.0pt; mso-bidi-font-style: normal
}
A:link {
COLOR: blue; TEXT-DECORATION: underline; text-underline: single
}
SPAN.MsoHyperlink {
COLOR: blue; TEXT-DECORATION: underline; text-underline: single
}
A:visited {
COLOR: purple; TEXT-DECORATION: underline; text-underline: single
}
SPAN.MsoHyperlinkFollowed {
COLOR: purple; TEXT-DECORATION: underline; text-underline: single
}
STRONG {
mso-bidi-font-weight: normal
}
P {
FONT-SIZE: 12pt; MARGIN: 5pt 0in; FONT-FAMILY: "Arial Unicode MS"; mso-ansi-language: EN-GB; mso-pagination: widow-orphan; mso-bidi-font-family: "Times New Roman"; mso-bidi-font-size: 10.0pt
}
DIV.Section1 {
page: Section1
}
OL {
MARGIN-BOTTOM: 0in
}
UL {
MARGIN-BOTTOM: 0in
}
</STYLE>
</HEAD>
<BODY lang=EN-US style="tab-interval: .5in" vLink=purple link=blue
bgColor=#ffffff>
<DIV> </DIV>
<DIV style="FONT: 10pt arial">----- Original Message -----
<DIV style="BACKGROUND: #e4e4e4; font-color: black"><B>From:</B> <A
title=Joana.Camilo@grices.mctes.pt
href="mailto:Joana.Camilo@grices.mctes.pt">Joana Camilo</A> </DIV>
<DIV><B>Cc:</B> <A title=ana.micheli@grices.mctes.pt
href="mailto:ana.micheli@grices.mctes.pt">Ana Micheli</A> </DIV>
<DIV><B>Sent:</B> Monday, March 06, 2006 3:52 PM</DIV>
<DIV><B>Subject:</B> Divulgação - NANOTECHNOLOGY IN PHARMACEUTICALS AND BIOTECH,
24-26 April 2006</DIV></DIV>
<DIV><BR></DIV>
<DIV class=OutlookMessageHeader lang=en-us dir=ltr align=left><FONT face=Tahoma
size=2><SPAN class=320521012-02032006>
<P class=MsoNormal><SPAN lang=PT
style="FONT-SIZE: 10pt; FONT-FAMILY: Tahoma; mso-ansi-language: PT">Exmos.
Senhoras e Senhores,</SPAN><SPAN lang=PT
style="FONT-SIZE: 10pt; mso-ansi-language: PT"><o:p></o:p></SPAN></P>
<P class=MsoNormal><SPAN lang=PT
style="FONT-SIZE: 10pt; FONT-FAMILY: Tahoma; mso-ansi-language: PT"> </SPAN><SPAN
lang=PT style="FONT-SIZE: 10pt; mso-ansi-language: PT"><o:p></o:p></SPAN></P>
<P class=MsoNormal><SPAN lang=PT
style="FONT-SIZE: 10pt; FONT-FAMILY: Tahoma; mso-ansi-language: PT">Serve o
presente para ampliar a divulgação do evento <B
style="mso-bidi-font-weight: normal"><EM>NANOTECHNOLOGY IN PHARMACEUTICALS AND
BIOTECH</EM></B>, que decorrerá entre os dias 24 e 26 de Abril de 2006, em
Amesterdão.</SPAN><SPAN lang=PT
style="FONT-SIZE: 10pt; mso-ansi-language: PT"><o:p></o:p></SPAN></P>
<P class=MsoNormal><SPAN lang=PT
style="FONT-SIZE: 10pt; mso-ansi-language: PT"> <o:p></o:p></SPAN></P>
<P class=MsoNormal><SPAN lang=PT
style="FONT-SIZE: 10pt; FONT-FAMILY: Tahoma; mso-ansi-language: PT">Para mais
informações, aconselha-se a leitura que em baixo se reencaminha.</SPAN><SPAN
lang=PT style="FONT-SIZE: 10pt; mso-ansi-language: PT"><o:p></o:p></SPAN></P>
<P class=MsoNormal><SPAN lang=PT
style="FONT-SIZE: 10pt; mso-ansi-language: PT"> <o:p></o:p></SPAN></P>
<P class=MsoNormal><SPAN lang=PT
style="FONT-SIZE: 10pt; FONT-FAMILY: Tahoma; mso-ansi-language: PT">Com os
melhores cumprimentos,</SPAN><SPAN lang=PT
style="FONT-SIZE: 10pt; mso-ansi-language: PT"><o:p></o:p></SPAN></P>
<P class=MsoNormal><SPAN lang=PT
style="FONT-SIZE: 10pt; FONT-FAMILY: Tahoma; mso-ansi-language: PT">Joana
Camilo</SPAN><SPAN lang=PT
style="FONT-SIZE: 10pt; mso-ansi-language: PT"><o:p></o:p></SPAN></P></SPAN></FONT></DIV>
<DIV class=OutlookMessageHeader lang=en-us dir=ltr align=left><FONT face=Arial
color=#0000ff size=2><SPAN class=320521012-02032006></SPAN></FONT> </DIV>
<DIV class=OutlookMessageHeader lang=en-us dir=ltr align=left><FONT face=Arial
color=#0000ff size=2><SPAN class=320521012-02032006>
<DIV align=left><FONT face=Arial size=2><FONT size=2><FONT color=#000000><SPAN
lang=PT style="FONT-SIZE: 11pt; FONT-FAMILY: Tahoma"> </DIV>
<P class=MsoNormal align=left><st1:PersonName
style="BACKGROUND-POSITION: left bottom; BACKGROUND-IMAGE: url(res://ietag.dll/#34/#1001); BACKGROUND-REPEAT: repeat-x"
tabIndex=0 w:st="on"><FONT face=Tahoma size=2><SPAN lang=PT
style="FONT-SIZE: 10pt; FONT-FAMILY: Tahoma">Joana
Camilo</SPAN></FONT></st1:PersonName><B><FONT face=Verdana size=2><SPAN lang=PT
style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Verdana"></SPAN></FONT></B></P>
<P class=MsoNormal align=left><B><FONT face=Verdana size=2><SPAN lang=PT
style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Verdana">GRICES</SPAN></FONT></B><FONT
face=Verdana size=2><SPAN lang=PT style="FONT-SIZE: 10pt; FONT-FAMILY: Verdana">
- Gabinete de Relações Internacionais da Ciência e do Ensino Superior
<BR>Ministério da Ciência, Tecnologia e Ensino Superior<BR>Av. 5 de Outubro, 85,
5º <BR>1050-050 Lisboa<BR>Tel.: (351) - 217828309<BR>Fax.: (351) -
217971687<BR>E-mail: </SPAN></FONT><FONT face=Verdana size=2><SPAN
style="FONT-SIZE: 10pt; FONT-FAMILY: Verdana"><A
title=mailto:joana.camilo@grices.mcies.pt
href="mailto:joana.camilo@grices.mctes.pt"><SPAN lang=PT
title=mailto:joana.camilo@grices.mcies.pt>joana.camilo@grices.mctes.pt</SPAN></A></SPAN></FONT></SPAN></FONT></FONT><FONT
face=Tahoma color=#000000 size=2><SPAN lang=PT
style="FONT-SIZE: 11pt"><o:p> </o:p></SPAN></FONT></P>
<P class=MsoNormal align=left><FONT face=Tahoma color=#000000><SPAN lang=PT
style="FONT-SIZE: 10pt; FONT-FAMILY: Arial"><o:p> </o:p></SPAN></FONT></P>
<P class=MsoNormal align=left><FONT face=Tahoma color=#000000><SPAN lang=PT
style="FONT-SIZE: 10pt; FONT-FAMILY: Arial"><o:p></o:p></SPAN></FONT></FONT></SPAN></FONT><BR> </P></DIV>
<DIV class=OutlookMessageHeader lang=en-us dir=ltr align=left>
<HR tabIndex=-1>
<FONT face=Tahoma size=2><B>From:</B> Visiongain Conferences
[mailto:NHI.14@reply.mb00.net] <BR><B>Subject:</B> NANOTECHNOLOGY IN
PHARMACEUTICALS AND BIOTECH, 24-26 April 2006<BR></FONT><BR></DIV>
<DIV></DIV>
<DIV class=Section1>
<H3><B style="mso-bidi-font-weight: normal"><SPAN lang=EN-GB
style="FONT-SIZE: 10pt; FONT-FAMILY: Arial; TEXT-DECORATION: none; mso-bidi-font-family: 'Times New Roman'; text-underline: none">====================================================================<O:P></O:P></SPAN></B></H3>
<H3><B style="mso-bidi-font-weight: normal"><SPAN lang=EN-GB
style="FONT-SIZE: 10pt; FONT-FAMILY: Arial; TEXT-DECORATION: none; mso-bidi-font-family: 'Times New Roman'; text-underline: none">NANOTECHNOLOGY
IN PHARMACEUTICALS AND BIOTECH<O:P></O:P></SPAN></B></H3>
<P class=MsoBodyText2><SPAN lang=EN-GB
style="FONT-SIZE: 10pt; FONT-STYLE: normal; FONT-FAMILY: Arial; mso-bidi-font-family: 'Times New Roman'">Examining
progress towards commercialisation of nanotechnology in drug discovery,
development, delivery and diagnostics.<O:P></O:P></SPAN></P>
<P class=MsoNormal><SPAN lang=EN-GB
style="FONT-FAMILY: Arial; mso-bidi-font-family: 'Times New Roman'">24<SUP>th</SUP>
– 26<SUP>th</SUP><SPAN style="mso-spacerun: yes"> </SPAN>April 2006,
NH-Amsterdam Centre, Amsterdam<O:P></O:P></SPAN></P>
<P class=MsoNormal><B style="mso-bidi-font-weight: normal"><SPAN lang=EN-GB
style="FONT-FAMILY: Arial; mso-bidi-font-family: 'Times New Roman'">====================================================================<O:P></O:P></SPAN></B></P>
<P class=MsoNormal><B style="mso-bidi-font-weight: normal"><SPAN lang=EN-GB
style="FONT-FAMILY: Arial; mso-bidi-font-family: 'Times New Roman'"><![if !supportEmptyParas]><![endif]><O:P></O:P></SPAN></B></P>
<P class=MsoNormal><SPAN lang=EN-GB
style="FONT-FAMILY: Arial; mso-bidi-font-family: 'Times New Roman'">View all
events at <A
href="http://www.visiongainconferences.com">www.visiongainconferences.com</A>
<O:P></O:P></SPAN></P>
<P class=MsoNormal><SPAN lang=EN-GB
style="FONT-FAMILY: Arial; mso-bidi-font-family: 'Times New Roman'"><![if !supportEmptyParas]><![endif]><O:P></O:P></SPAN></P>
<P class=MsoNormal><SPAN lang=EN-GB
style="FONT-FAMILY: Arial; mso-bidi-font-family: 'Times New Roman'">An
increasing use of nanotechnology by the pharmaceutical and biotechnology
industries is widely anticipated – the global market for medical nanotechnology
is expected to be more than $3 billion in 5 years. Currently 61 nanotech-based
drugs and delivery systems and 91 devices or diagnostic tests have entered
preclinical, clinical, or commercial development. <O:P></O:P></SPAN></P>
<P class=MsoNormal><SPAN lang=EN-GB
style="FONT-FAMILY: Arial; mso-bidi-font-family: 'Times New Roman'"><![if !supportEmptyParas]><![endif]><O:P></O:P></SPAN></P>
<P class=MsoNormal><SPAN lang=EN-GB
style="FONT-FAMILY: Arial; mso-bidi-font-family: 'Times New Roman'">This two-day
conference will bring together key decision makers and international experts in
the field of nanotechnology. Delegates and speakers will come from
pharmaceutical companies and technology providers using nanotechnology for drug
discovery, development, delivery and nanomedicine. <O:P></O:P></SPAN></P>
<P class=MsoNormal><SPAN lang=EN-GB
style="FONT-FAMILY: Arial; mso-bidi-font-family: 'Times New Roman'"><![if !supportEmptyParas]><![endif]><O:P></O:P></SPAN></P>
<P class=MsoNormal><A name=_Hlk127264116></A><A
href="http://www.visiongainconferences.com/conferenceInfo.aspx?confID=1046&bookingCode=CM"><SPAN
style="mso-bookmark: _Hlk127264116"><SPAN lang=EN-GB
style="FONT-FAMILY: Arial; mso-bidi-font-family: 'Times New Roman'">Download the
conference <SPAN
style="mso-bookmark: _Hlt127264138">b</SPAN>rochure</SPAN></SPAN><SPAN
style="mso-bookmark: _Hlk127264116"></SPAN></A><![if !supportNestedAnchors]><A
name=_Hlt127264138></A><![endif]><SPAN lang=EN-GB
style="COLOR: red; FONT-FAMILY: Arial; mso-bidi-font-family: 'Times New Roman'"><O:P></O:P></SPAN></P>
<P class=MsoNormal><SPAN lang=EN-GB
style="FONT-FAMILY: Arial; mso-bidi-font-family: 'Times New Roman'"><SPAN
style="mso-spacerun: yes"></SPAN><O:P></O:P></SPAN></P>
<P class=MsoNormal><B style="mso-bidi-font-weight: normal"><SPAN lang=EN-GB
style="LAYOUT-GRID-MODE: line; FONT-FAMILY: Arial; mso-bidi-font-family: 'Times New Roman'">BY
ATTENDING THE CONFERENCE YOU WILL LEARN ABOUT: </SPAN></B><SPAN lang=EN-GB
style="FONT-FAMILY: Arial; mso-bidi-font-family: 'Times New Roman'"><O:P></O:P></SPAN></P>
<P class=MsoNormal
style="MARGIN-LEFT: 0.5in; TEXT-INDENT: -0.25in; mso-list: l0 level1 lfo2"><![if !supportLists]><SPAN
lang=EN-GB style="FONT-FAMILY: Symbol">·<SPAN
style="FONT: 7pt 'Times New Roman'">
</SPAN></SPAN><![endif]><STRONG><SPAN lang=EN-GB
style="FONT-FAMILY: Arial; mso-bidi-font-family: 'Times New Roman'">Drug
Delivery:</SPAN></STRONG><SPAN lang=EN-GB
style="FONT-FAMILY: Arial; mso-bidi-font-family: 'Times New Roman'"> learn how
nanotechnology will benefit the different delivery formats - injectable, oral,
implantable, transdermal, etc. <O:P></O:P></SPAN></P>
<P class=MsoNormal
style="MARGIN-LEFT: 0.5in; TEXT-INDENT: -0.25in; mso-list: l0 level1 lfo2"><![if !supportLists]><SPAN
lang=EN-GB style="FONT-FAMILY: Symbol">·<SPAN
style="FONT: 7pt 'Times New Roman'">
</SPAN></SPAN><![endif]><STRONG><SPAN lang=EN-GB
style="FONT-FAMILY: Arial; mso-bidi-font-family: 'Times New Roman'">Drug
Discovery:</SPAN></STRONG><SPAN lang=EN-GB
style="FONT-FAMILY: Arial; mso-bidi-font-family: 'Times New Roman'"> examine the
potential of different nanotechnology-based tools for improving imaging,
screening and research techniques, including nanolithography, nanoarrays and
mass spectrometry <O:P></O:P></SPAN></P>
<P class=MsoNormal
style="MARGIN-LEFT: 0.5in; TEXT-INDENT: -0.25in; mso-list: l0 level1 lfo2"><![if !supportLists]><SPAN
lang=EN-GB style="FONT-FAMILY: Symbol">·<SPAN
style="FONT: 7pt 'Times New Roman'">
</SPAN></SPAN><![endif]><STRONG><SPAN lang=EN-GB
style="FONT-FAMILY: Arial; mso-bidi-font-family: 'Times New Roman'">Drug
Development:</SPAN></STRONG><SPAN lang=EN-GB
style="FONT-FAMILY: Arial; mso-bidi-font-family: 'Times New Roman'"> discover
the advantages of nanoparticle formulations for resolving solubility issues and
increasing the number of compounds available for potential development
<O:P></O:P></SPAN></P>
<P class=MsoNormal
style="MARGIN-LEFT: 0.5in; TEXT-INDENT: -0.25in; mso-list: l0 level1 lfo2"><![if !supportLists]><SPAN
lang=EN-GB style="FONT-FAMILY: Symbol">·<SPAN
style="FONT: 7pt 'Times New Roman'">
</SPAN></SPAN><![endif]><STRONG><SPAN lang=EN-GB
style="FONT-FAMILY: Arial; mso-bidi-font-family: 'Times New Roman'">Diagnostics:</SPAN></STRONG><SPAN
lang=EN-GB style="FONT-FAMILY: Arial; mso-bidi-font-family: 'Times New Roman'">
find out how quantum dots can be used to tag biological targets of choice
<O:P></O:P></SPAN></P>
<P class=MsoNormal
style="MARGIN-LEFT: 0.5in; TEXT-INDENT: -0.25in; mso-list: l0 level1 lfo2"><![if !supportLists]><SPAN
lang=EN-GB style="FONT-FAMILY: Symbol">·<SPAN
style="FONT: 7pt 'Times New Roman'">
</SPAN></SPAN><![endif]><STRONG><SPAN lang=EN-GB
style="FONT-FAMILY: Arial; mso-bidi-font-family: 'Times New Roman'">Therapeutics:</SPAN></STRONG><SPAN
lang=EN-GB style="FONT-FAMILY: Arial; mso-bidi-font-family: 'Times New Roman'">
determine the potential of nano-based compounds for targeting tumours and
cancers <O:P></O:P></SPAN></P>
<P class=MsoNormal
style="MARGIN-LEFT: 0.5in; TEXT-INDENT: -0.25in; mso-list: l0 level1 lfo2"><![if !supportLists]><SPAN
lang=EN-GB style="FONT-FAMILY: Symbol">·<SPAN
style="FONT: 7pt 'Times New Roman'">
</SPAN></SPAN><![endif]><STRONG><SPAN lang=EN-GB
style="FONT-FAMILY: Arial; mso-bidi-font-family: 'Times New Roman'">Commercialisation
Strategies:</SPAN></STRONG><SPAN lang=EN-GB
style="FONT-FAMILY: Arial; mso-bidi-font-family: 'Times New Roman'"> hear from
leading pharma executives and management consultants on how to successfully
develop your nanobusiness<O:P></O:P></SPAN></P>
<P class=MsoNormal><B style="mso-bidi-font-weight: normal"><SPAN lang=EN-GB
style="FONT-FAMILY: Arial; mso-bidi-font-family: 'Times New Roman'"><![if !supportEmptyParas]><![endif]><O:P></O:P></SPAN></B></P>
<P class=MsoNormal><B style="mso-bidi-font-weight: normal"><SPAN lang=EN-GB
style="FONT-FAMILY: Arial; mso-bidi-font-family: 'Times New Roman'">KEY SPEAKERS
INCLUDE:<O:P></O:P></SPAN></B></P>
<P class=MsoNormal><B style="mso-bidi-font-weight: normal"><SPAN lang=EN-GB
style="FONT-FAMILY: Arial; mso-bidi-font-family: 'Times New Roman'">Dr. Jianling
Wang</SPAN></B><SPAN lang=EN-GB
style="FONT-FAMILY: Arial; mso-bidi-font-family: 'Times New Roman'">, Head eADME
Programme, Novartis Institute for Biomedical research <BR><B
style="mso-bidi-font-weight: normal">Steve Ellul</B>, Director, Business
Development, Eurand Pharmaceuticals <BR><B
style="mso-bidi-font-weight: normal">Dr. Stephen Barry</B>, President, Alnis
BioSciences <BR><B style="mso-bidi-font-weight: normal">Dr. Barrett E.
Rabinow</B>, Director of Strategic Development, Baxter Healthcare <BR><B
style="mso-bidi-font-weight: normal">Dr. Donald A. Tomalia</B>, President and
Chief Technology Officer, Dendritic Nanotechnologies<O:P></O:P></SPAN></P>
<P class=MsoNormal><B style="mso-bidi-font-weight: normal"><SPAN lang=EN-GB
style="FONT-FAMILY: Arial; mso-bidi-font-family: 'Times New Roman'">David
Manser</SPAN></B><SPAN lang=EN-GB
style="FONT-FAMILY: Arial; mso-bidi-font-family: 'Times New Roman'">, Scientist,
Elan Drug Technology<O:P></O:P></SPAN></P>
<P class=MsoNormal><B style="mso-bidi-font-weight: normal"><SPAN lang=EN-GB
style="FONT-FAMILY: Arial; mso-bidi-font-family: 'Times New Roman'">Ottilia
Saxl</SPAN></B><SPAN lang=EN-GB
style="FONT-FAMILY: Arial; mso-bidi-font-family: 'Times New Roman'">, CEO,
Institute of Nanotechnology<O:P></O:P></SPAN></P>
<P class=MsoNormal><SPAN lang=EN-GB
style="FONT-FAMILY: Arial; mso-bidi-font-family: 'Times New Roman'"><![if !supportEmptyParas]><![endif]><O:P></O:P></SPAN></P>
<P class=MsoNormal><B style="mso-bidi-font-weight: normal"><SPAN lang=EN-GB
style="FONT-FAMILY: Arial; mso-bidi-font-family: 'Times New Roman'">INTERACTIVE
WORKSHOP<O:P></O:P></SPAN></B></P>
<P class=MsoNormal><B style="mso-bidi-font-weight: normal"><SPAN lang=EN-GB
style="FONT-FAMILY: Arial; mso-bidi-font-family: 'Times New Roman'">24 April
2006<BR></SPAN></B><SPAN lang=EN-GB
style="FONT-FAMILY: Arial; mso-bidi-font-family: 'Times New Roman'">The
Commercialisation of Nanotechnology<BR><B
style="mso-bidi-font-weight: normal">Led By: </B>Barrett E. Rabinow, , Baxter
Healthcare<O:P></O:P></SPAN></P>
<P class=MsoNormal><SPAN lang=EN-GB
style="FONT-FAMILY: Arial; mso-bidi-font-family: 'Times New Roman'"><![if !supportEmptyParas]><![endif]><O:P></O:P></SPAN></P>
<P class=MsoNormal><SPAN lang=EN-GB
style="COLOR: red; FONT-FAMILY: Arial; mso-bidi-font-family: 'Times New Roman'"><A
href="http://www.visiongainconferences.com/conferenceInfo.aspx?confID=1046&bookingCode=CM">Download
the conference brochure</A><O:P></O:P></SPAN></P>
<P class=MsoNormal><SPAN lang=EN-GB
style="FONT-FAMILY: Arial; mso-bidi-font-family: 'Times New Roman'"><![if !supportEmptyParas]><![endif]><O:P></O:P></SPAN></P>
<H1><SPAN lang=EN-GB>DELEGATE REGISTRATION</SPAN></H1>
<P class=MsoNormal><SPAN
style="LAYOUT-GRID-MODE: line; FONT-FAMILY: Arial; mso-ansi-language: EN-US; mso-bidi-font-family: 'Times New Roman'">Places
at this event are strictly limited so BOOK YOUR PLACE NOW.<O:P></O:P></SPAN></P>
<P class=MsoNormal><SPAN
style="LAYOUT-GRID-MODE: line; FONT-FAMILY: Arial; mso-ansi-language: EN-US; mso-bidi-font-family: 'Times New Roman'">To
make a booking on this event, please contact me via phone or email.
Book<O:P></O:P></SPAN></P>
<P class=MsoNormal><SPAN
style="LAYOUT-GRID-MODE: line; FONT-FAMILY: Arial; mso-ansi-language: EN-US; mso-bidi-font-family: 'Times New Roman'">Early
to secure a place.<O:P></O:P></SPAN></P>
<P class=MsoNormal><SPAN
style="LAYOUT-GRID-MODE: line; FONT-FAMILY: Arial; mso-ansi-language: EN-US; mso-bidi-font-family: 'Times New Roman'"><![if !supportEmptyParas]><![endif]><O:P></O:P></SPAN></P>
<H1><SPAN lang=EN-GB>PRICING</SPAN></H1>
<P class=MsoNormal><SPAN
style="LAYOUT-GRID-MODE: line; FONT-FAMILY: Arial; mso-ansi-language: EN-US; mso-bidi-font-family: 'Times New Roman'">Attend
the:<O:P></O:P></SPAN></P>
<P class=MsoNormal><SPAN
style="LAYOUT-GRID-MODE: line; FONT-FAMILY: Arial; mso-ansi-language: EN-US; mso-bidi-font-family: 'Times New Roman'">Two
Day conference with interactive workshop - ONLY GBP1699plus
VAT<O:P></O:P></SPAN></P>
<P class=MsoNormal><SPAN
style="LAYOUT-GRID-MODE: line; FONT-FAMILY: Arial; mso-ansi-language: EN-US; mso-bidi-font-family: 'Times New Roman'">Two
Day conference - ONLY GBP1299 plus VAT<O:P></O:P></SPAN></P>
<P class=MsoNormal><SPAN
style="LAYOUT-GRID-MODE: line; FONT-FAMILY: Arial; mso-ansi-language: EN-US; mso-bidi-font-family: 'Times New Roman'">Workshop
only - ONLY GBP599 plus VAT<O:P></O:P></SPAN></P>
<P class=MsoNormal><SPAN
style="LAYOUT-GRID-MODE: line; FONT-FAMILY: Arial; mso-ansi-language: EN-US; mso-bidi-font-family: 'Times New Roman'"><![if !supportEmptyParas]><![endif]><O:P></O:P></SPAN></P>
<H1><SPAN lang=EN-GB>BOOKINGS</SPAN></H1>
<P class=MsoNormal><SPAN
style="LAYOUT-GRID-MODE: line; FONT-FAMILY: Arial; mso-ansi-language: EN-US; mso-bidi-font-family: 'Times New Roman'">Booking
is easy, simply contact Ming-Wai Wong on:<O:P></O:P></SPAN></P>
<P class=MsoNormal><SPAN
style="LAYOUT-GRID-MODE: line; FONT-FAMILY: Arial; mso-ansi-language: EN-US; mso-bidi-font-family: 'Times New Roman'"><![if !supportEmptyParas]><![endif]><O:P></O:P></SPAN></P>
<P class=MsoNormal><SPAN
style="LAYOUT-GRID-MODE: line; FONT-FAMILY: Arial; mso-ansi-language: EN-US; mso-bidi-font-family: 'Times New Roman'">Telephone:
+44 (0)20 8767 6711<O:P></O:P></SPAN></P>
<P class=MsoNormal><SPAN
style="LAYOUT-GRID-MODE: line; FONT-FAMILY: Arial; mso-ansi-language: EN-US; mso-bidi-font-family: 'Times New Roman'">Fax:
+44 (0)20 8767 5001<O:P></O:P></SPAN></P>
<P class=MsoNormal><SPAN
style="LAYOUT-GRID-MODE: line; FONT-FAMILY: Arial; mso-ansi-language: EN-US; mso-bidi-font-family: 'Times New Roman'">Terms
and conditions apply - see below<O:P></O:P></SPAN></P>
<P class=MsoNormal><SPAN
style="LAYOUT-GRID-MODE: line; FONT-FAMILY: Arial; mso-ansi-language: EN-US">Email:
mailto:<A href="mailto:ming-wai.wong@visiongaingroup.com"><SPAN lang=EN-GB
style="LAYOUT-GRID-MODE: both; mso-ansi-language: EN-GB">mailto:ming-wai.wong@visiongaingroup.com</SPAN></A><O:P></O:P></SPAN></P>
<P class=MsoNormal><SPAN
style="LAYOUT-GRID-MODE: line; FONT-FAMILY: Arial; mso-ansi-language: EN-US; mso-bidi-font-family: 'Times New Roman'"><![if !supportEmptyParas]><![endif]><O:P></O:P></SPAN></P>
<H1><SPAN lang=EN-GB>US FREEPHONE BOOKING HOTLINE</SPAN></H1>
<P class=MsoNormal><SPAN
style="LAYOUT-GRID-MODE: line; FONT-FAMILY: Arial; mso-ansi-language: EN-US; mso-bidi-font-family: 'Times New Roman'">Please
call and ask for Jonathan Bowerbank quoting my name on
booking.<O:P></O:P></SPAN></P>
<P class=MsoNormal><SPAN
style="LAYOUT-GRID-MODE: line; FONT-FAMILY: Arial; mso-ansi-language: EN-US; mso-bidi-font-family: 'Times New Roman'">+1
866 956 3001<O:P></O:P></SPAN></P>
<P class=MsoNormal><SPAN lang=EN-GB
style="LAYOUT-GRID-MODE: line; FONT-FAMILY: Arial; mso-bidi-font-family: 'Times New Roman'"><![if !supportEmptyParas]><![endif]><O:P></O:P></SPAN></P>
<P class=MsoBodyText><SPAN
style="FONT-SIZE: 10pt; mso-bidi-font-size: 12.0pt">For questions about the
conference, please contact: <A
href="mailto:charlotte.metcalfe@visiongain.com"><SPAN lang=EN-GB
style="mso-ansi-language: EN-GB; mso-bidi-font-size: 10.0pt">charlotte.metcalfe@visiongain.com</SPAN></A>.<O:P></O:P></SPAN></P></DIV><BR><BR>
<DIV align=center><FONT face=helvetica,arial color=#000000 size=-1><A
href="http://i.mb00.net/subscribe?server_action=Unsubscribe&list=NHI&sublist=14&msgid=1139509418.9950&email_address=paula.pereira%40grices.mces.pt">Remove
yourself from future email here</A> or reply to this message with the word
'remove' in your email message subject line. <BR></FONT></DIV><BR>
<DIV align=center><FONT face=helvetica,arial color=#000000 size=1>This message
was sent to paula.pereira@grices.mces.pt<BR><FONT color=#cccccc
size=1>pmguid:uj.f8w5.3p72</FONT> </FONT></DIV><!--
X-PMG-Recipient: paula.pereira@grices.mces.pt
X-PMG-Msgid: 1139509418.9950
X-PMG-Userid: NHI:14
--><BR clear=all><IMG height=12 alt=pmg
src="http://r.pm0.net/s/o?uj.f8w5.0.3p72" width=33 align=right border=0
NOSEND="1"> </BODY></HTML>